Literature DB >> 12571537

Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy.

Luis F López-Cortés, Rosa Ruiz-Valderas, Pompeyo Viciana, Rosario Mata, Josefa Gómez-Vera, Arístides Alarcón, Jerónimo Pachón.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12571537     DOI： 10.1097/00126334-200302010-00019

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients.

Authors:  Ana Marin-Niebla; Luis Fernando Lopez-Cortes; Rosa Ruiz-Valderas; Pompeyo Viciana; Rosario Mata; Alicia Gutierrez; Rosario Pascual; Magdalena Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

Review 2.  Saquinavir: a review of its use in boosted regimens for treating HIV infection.

Authors:  Greg L Plosker; Lesley J Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.

Authors:  Luis F López-Cortés; Pompeyo Viciana; Rosa Ruiz-Valderas; Juan Pasquau; Josefa Ruiz; Fernando Lozano; Dolores Merino; Antonio Vergara; Alberto Terrón; Luis González; Antonio Rivero; Agustin Muñoz-Sanz
Journal:  AIDS Res Ther       Date:  2010-03-17       Impact factor: 2.250

4.  Potential Hepatotoxicity of Efavirenz and Saquinavir/Ritonavir Coadministration in Healthy Volunteers.

Authors:  Candice Jamois; Myriam Riek; Christophe Schmitt
Journal:  Arch Drug Inf       Date:  2009-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.